A CDC spokesperson told The Epoch Times via email: "CDC has been continuously monitoring the safety of COVID-19 vaccines since they began to be administered in the United States. At the time of the director's press conference, CDC did not have sufficient evidence to conclude there was a safety signal for myocarditis following mRNA COVID-19 vaccination."
The CDC has told The Epoch Times that its 2022 detection of a signal for myocarditis using PRRs was "Consistent with" the data mining results.
Another CDC vaccine safety monitoring system, V-safe, did not include myocarditis despite the CDC and FDA identifying the heart inflammation as an adverse event of special interest, or a possible side effect, for the COVID-19 vaccines before they were authorized.
The Vaccine Safety Datalink did include myocarditis but did not detect a signal until 2022, possibly because it was using a too-narrow case definition.
French experts said in a separate paper, after analyzing 214 reports of myocarditis following COVID-19 vaccination, that their data "Suggests that, similar to other vaccines, mRNA COVID-19 vaccines are associated with myocarditis." First Acknowledgement Israeli media reported in April 2021 a second post-vaccination myocarditis death, a 35-year-old previously healthy young man.
Dr. Vinay Prasad, a California epidemiologist, was another, calling myocarditis "a clear and large safety signal in young men."
The outlier scenario projected 156 excess myocarditis hospitalizations, compared to just 21 prevented COVID hospitalizations, among males aged 5 to 11, and 28 excess myocarditis hospitalizations compared to 21 prevented COVID hospitalizations among females of the same age group.
No comments:
Post a Comment